RetinalGenix Technologies Inc.
RTGN
$3.20
-$0.35-9.86%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.79% | 33.11% | 31.94% | 25.87% | -106.66% |
| Total Depreciation and Amortization | 188.89% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.78% | -33.73% | -42.06% | -34.01% | 176.46% |
| Change in Net Operating Assets | -12.34% | -45.73% | -51.25% | -66.57% | -54.33% |
| Cash from Operations | 24.75% | 27.08% | -35.91% | -42.28% | -64.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -45.27% | -66.57% | -89.67% | -98.70% | -92.27% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -23.14% | -29.43% | 106.13% | 375.33% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.18% | -41.86% | 4.61% | 23.72% | 65.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.26% | -199.75% | -201.18% | -208.62% | 6,200.00% |